Effect of Progressive Early Mobilization in Patients With TBI

February 5, 2024 updated by: National Taiwan University Hospital

Effect of Progressive Early Mobilization on Functional Recovery in Patients With Moderate-Severe Traumatic Brain Injury: a Single Blind, Randomized Controlled Trial

traumatic brain injury (TBI) is a major public health concern worldwide. Patients with moderate-severe TBI have high rates of disability at the acute phase and frequently require protracted rehabilitation with prolonged periods of recovery. Recently, it has been found that the use of progressive early mobilization (EM) protocols for critical trauma patients may minimize the functional declines during intensive care unit (ICU) stays. However, prior early mobilization studies have found that the survivors of moderate-severe TBI often experience a greater incidence of neurological injuries with other organ injury than other critical care patients. No randomized controlled trials thus far have utilized measure the influence or effect of early progressive EM protocols on the functional recovery of moderate-severe TBI patients.

Study Overview

Status

Completed

Detailed Description

Objective: The goals of this proposed research study are (1) to investigate the feasibility of using a structured progressive EM protocol for patients with moderate-severe TBI in a trauma ICU and (2) The goal is to investigate and compare the intervention effects of a progressive EM protocol (aimed at bringing patients at least to the mobility level-3 of sitting on the edge of bed) in an ICU on short-term and long-term functional abilities in patients with moderate-severe TBI.

Study Type

Interventional

Enrollment (Actual)

65

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Taipei, Taiwan, 110
        • National Taiwan University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Expected to stay for at least 72 hours in the ICU,
  • >20 years of age with living independently before the onset of critical illness
  • relatively stable vital signs with a Glasgow Coma Scale (GCS) score of ≥6
  • relatively stable respiratory status (SpO2 >92%, high mechanical ventilator setting: FiO2 ≤60%, and positive end-expiratory pressure ≤10 cmH2O)
  • stable cardiovascular system (resting heart rate ≤130 bpm or no use of high-dose vasopressor of more than 0.2 μg kg-1 min-1)

Exclusion Criteria:

  • predicted mortality within the next 24 hours
  • palliative care
  • consistent increase of intracranial pressure (>20 mmHg)
  • pregnancy
  • uncontrolled seizure
  • active bleeding
  • ruptured or leaking aortic aneurysm
  • development of acute myocardial infarction during ICU stay
  • rapid development of degenerative neuromuscular diseases
  • contraindication for early walking

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: standard early rehabilitation (SER) group
Patients in the SER group (Progressive upright positioning protocol) will receive standard physiotherapy including passive range of motion exercises, active exercises, bed mobility, and respiratory therapy during their ICU stays. In the SER group, out-of-bed mobilization (>=Level III in the Modified Trauma ICU Mobility Scale) will be started as soon as possible after ICU discharge but at least Level III (sitting on the edge of bed) above 7 days of onset.
The goal will be to achieve a mobilization level of at least Level III (sitting on the edge of bed) during the ICU stay (within 7 days).
Experimental: early mobilization (ER) group
Participants in the EM group will undergo the progressive early mobilization protocol in the trauma ICU in a manner consistent with the our hospital practice guidelines indicated by the Modified ICU Mobility Scale for progressive mobilization during the ICU stay. EM will be started with in-bed exercises and, if no medical contraindications are present, progressed from sitting in bed with the head tilted >60° to sitting on the edge of the bed to standing (including pre-gait exercises to improve postural stability, static and dynamic balance, and marching on the spot) and, finally, to walking.
The goal will be to achieve a mobilization level of at least Level III (sitting on the edge of bed) during the ICU stay (within 7 days).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The total score-change of the Perme ICU Mobility Score
Time Frame: at baseline; at the time of ICU discharge; the time of hospital discharge (an average of 30 days); three-month after onset
The Perme ICU Mobility Score ranges from 0 to 32 points and is obtained by summing the score of 15 items, each one scored from 2 to 3 points. This score reflects the patient's mobility status in specific circumstances.
at baseline; at the time of ICU discharge; the time of hospital discharge (an average of 30 days); three-month after onset

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
the days of achievement of the walking motor milestone
Time Frame: up to 3 months
walking on a level surface for ≥50 meters with or without an assistive device
up to 3 months
the length of stay in the ICU
Time Frame: up to 3 months
the length of stay in the ICU
up to 3 months
the hospital length of stay
Time Frame: up to 3 months
the hospital length of stay
up to 3 months
the days of ventilator used
Time Frame: up to 3 months
the days of ventilator used
up to 3 months
the discharge disposition after hospital discharge
Time Frame: up to 3 months
where a patient is being discharged - i.e. home, home with home care, skilled nursing facility, or rehab center.
up to 3 months
The total score-change of the motor domain of the Functional Independence Measure (FIM-motor)
Time Frame: at baseline; at the time of ICU discharge; the time of hospital discharge (an average of 30 days); three-month after onset
the FIM-motor consist of self-care tasks (eating, grooming, bathing, upper-body dressing, lower-body dressing, and using the toilet), sphincter control (bladder and bowel management), transfers (from bed or a chair to the toilet, bath, or shower), and locomotion ability (walking or wheelchair mobility, and stair climbing)
at baseline; at the time of ICU discharge; the time of hospital discharge (an average of 30 days); three-month after onset
the achievement level of Modified Trauma ICU Mobility Scale
Time Frame: at baseline; at the time of ICU discharge; the time of hospital discharge
the achievement of Modified Trauma ICU Mobility Scale, Level 0-10
at baseline; at the time of ICU discharge; the time of hospital discharge
the values tested by in body s10 about lean body mass parameters
Time Frame: at baseline; at the time of ICU discharge; the time of hospital discharge/ an average of 30 days;
including phase angle, skeletal muscle mass, body fat mass, total body water etc.
at baseline; at the time of ICU discharge; the time of hospital discharge/ an average of 30 days;

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Hung-Jui Chuang, Dr, Department of Physical Medicine and Rehabilitation

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 30, 2021

Primary Completion (Actual)

June 30, 2021

Study Completion (Actual)

January 17, 2024

Study Registration Dates

First Submitted

March 16, 2021

First Submitted That Met QC Criteria

March 19, 2021

First Posted (Actual)

March 22, 2021

Study Record Updates

Last Update Posted (Estimated)

February 6, 2024

Last Update Submitted That Met QC Criteria

February 5, 2024

Last Verified

January 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • 202012084RIN

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Trauma

Clinical Trials on Early progressive mobilization

3
Subscribe